You are here

Industry Trends

Insurer enlists CVS Health to help in replacing Express Scripts
Announcement follows judge’s ruling to toss patents
Sophisticated management of life-threatening complications could double cost of care
Reports indicate he worked to weaken federal efforts to restrict opioids
While restrictions are increasing, a third of plans impose none
Company considering sale or spin-off of multibillion-dollar OTC business
New trial ordered in dispute between Amgen and Sanofi/Regeneron
Work on MK-3682B and MK-3682C discontinued
Medication can launch in Europe a year from now
The cause, they said, involved an average of at least seven factors
Mobile reader gets measurements from sensor wire beneath the skin
Researchers blame high out-of-pocket costs and insurance snags
Paper-based diagnostic avoids false positives from Dengue fever
Nearly 50 pharmaceutical and device manufacturers operate on the island
Prosecutors: Juxtapid marketed too broadly and investors misled
FDA and some companies dispute findings of report in NEJM
Those in development are at best short-term solutions
Company aims to prevent Restasis challenges at U.S. patent office

Pages